Tackling Lyme Disease: What’s Worth Supporting and What’s Not

Lyme disease isn’t a new problem, but it’s one that’s getting harder to ignore. Each year, around half a million Americans get bitten by ticks carrying Borrelia bacteria, the germ behind Lyme. Most of the time, a few weeks of antibiotics will clear the infection if caught early. But for some, symptoms like fatigue stick around long after treatment ends. Doctors call this post-treatment Lyme disease syndrome, or PTLDS. The catch? No one’s totally sure why it happens. Some think it’s leftover immune system chaos from the infection, while others insist it’s proof of a hidden, ongoing infection—even though research doesn’t back that up. So why does this debate matter now? Because a new government plan aims to tackle Lyme and other tickborne diseases, and while some parts make sense—like funding research and reducing tick populations—other parts lean heavily into unproven ideas. The plan pushes the idea of "chronic Lyme, " a condition many experts argue doesn’t exist in the way it’s often described. Instead of focusing on solid science, the plan seems to give weight to doctors and groups that promote long-term antibiotics and untested treatments. That’s risky because these approaches can do more harm than good, including severe infections from unnecessary treatments.The plan also partners with groups like the International Lyme and Associated Diseases Society (ILADS), which has long supported the chronic Lyme theory. While the idea might sound comforting to those struggling with long-term symptoms, it’s led some patients down dangerous paths. There have been cases where people developed serious complications or even died because of treatments pushed by "Lyme-literate" providers. The government’s stamp of approval on these groups could legitimize practices that lack strong evidence. It’s not all bad news, though. Lyme disease is a real threat, and new tools—like vaccines—could help fight it. But here’s the twist: the plan barely mentions vaccines, despite several being in development. Meanwhile, the plan’s focus on "chronic Lyme" overshadows other important work, like improving testing or supporting patients with lingering symptoms. The government has a chance to do real good here, but it’s choosing to highlight ideas that divide the medical community instead.